Our progressive strategy of investing in under-ventured geographies and sectors, coupled with our expertise in building deep relationships with entrepreneurs, executives, and investment partners across the healthcare industry, are significant factors contributing to our success.
Venture the Path Less TraveledTM
A healthcare venture capital firm rooted in the Midwest
Medical Devices
Life Science Tools
& Diagnostics
Tech-Enabled
Care Delivery
Pharma
Adjacencies
Entrepreneurs
We seek innovations that solve (big) healthcare problems and make a transformational impact from teams who are diverse in thought, geography, and demographics.
Investors
We have a proven formula for identifying early-stage startups that can create value in a capital-efficient manner, accelerate portfolio value, and deliver superior returns.
Portfolio Spotlight
We invest in today’s ideas to forge a path for better healthcare tomorrow
Where NeuMoDx started?
Molecular diagnostics is one of the fastest-growing segments within the in-vitro diagnostics market, but existing systems are expensive, complex, and lack sophisticated automation. Through a unique combination of automation and microfluidics, the NeuMoDx Molecular clinical PCR systems offer best-in-class ease of use, throughput, and cost per test.
Where NeuMoDx is today?
Arboretum collaborated with the team to set the strategic direction that helped accelerate the company’s product development timeline and helped recruit new investors. Since Arboretum’s investment, NeuMoDx gained regulatory approvals for its first assays, launched its product, and in September 2020, QIAGEN acquired NeuMoDx to strengthen its portfolio of automated molecular testing.
We fuel the future of healthcare
700M+
under management across five funds
75
of the portfolio invested in under-ventured markets over 20 years
44
of all active companies have either a female / minority CEO or founder
16
patient - lives impacted
Shifting the venture capital paradigm
We are proud to be a Midwest venture capital firm operating with transparency, integrity, and approachability to help you realize your entrepreneurial and investor goals. Together, we’ll positively impact patients, communities, and healthcare.
Testimonials
In the News
Jan Garfinkle Receives NVCA’s Venture Vanguard Award
In observance of its 50th anniversary, the National Venture Capital Association (NVCA) is pleased to formally launch its new Venture Vanguard Award, an initiative that recognizes exceptional individuals who have…
Read More
Fifth Eye’s AHI System™ for Predictive Patient Analytics Now Available in Medical Informatics Corp.’s Sickbay™ Platform
Fifth Eye Inc., a provider of real-time clinical analytics, is pleased to announce that their Analytic for Hemodynamic Instability (AHI) is now available to customers using Medical Informatics Corp.’s Sickbay™…
Read More
Akadeum Launches T Cell Activation and Expansion Using Positive Selection and Expands Leukopak Cell Isolation Product Lines
Akadeum Life Sciences, a global leader in buoyancy-based cell separation and activation technology, is announcing the launch of a new series of products for cell therapy research and development—enabling direct…
Read More
